Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2015 Nov 26;2015:bcr2015210498. doi: 10.1136/bcr-2015-210498

Generalised reversible encephalopathy syndrome: a variant of posterior reversible encephalopathy syndrome (PRES)

Julia Kunzmann 1, Hubert Wolf 1, Stefan Oberndorfer 1
PMCID: PMC4680295  PMID: 26611477

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinical-radiological syndrome characterised by headache, visual disturbance, seizures and altered consciousness. Radiological findings show hyperintense T2-lesions on MRI, predominantly located in the subcortical white matter of the posterior occipital and parietal lobes. We report the case of a 74-year-old woman with adenocarcinoma of the gastric cardia who developed severe neurological signs and symptoms. MRI of the brain showed atypical generalised hyperintense lesions on T2 and fluid-attenuated inversion recovery sequences. Under symptomatic treatment, the radiological changes as well as neurological signs and symptoms improved. Several potential risk factors for PRES, such as hypertensive crisis, blood transfusions, infection and cancer, were identified in our patient, whereby perhaps the coexistence of these risk factors led to the unusual radiological and clinical manifestation of a generalised PRES variant.

Background

Posterior reversible encephalopathy syndrome (PRES) is a clinical-radiological condition.1 Clinical manifestation is characterised by headache, visual disturbance, alteration of consciousness and seizures.1–3 Seizures are often the presenting symptom; these can occur in series and are mostly generalised tonic–clonic.4 Other neurological signs such as paresis are uncommon.2 The classical imaging findings on MRI are hyperintense lesions on T2 sequences and fluid-attenuated inversion recovery (FLAIR), predominantly located in the subcortical white matter of the posterior occipital and parietal lobes.1 5 6 MRI manifestation of PRES can also occur in atypical locations involving the cerebellum, brainstem, basal ganglia, deep white matter and the cortex.3

Diagnosis of PRES can only be established in the case of concordant clinical and radiological findings.1 While the exact pathogenesis remains unclear, several causes and risk factors are known, including hypertension, pre-eclampsia, renal failure, severe infection/sepsis, immunosuppressive therapy and autoimmune diseases.3 7 8 Treatment of PRES is targeted at identifying and eliminating the potential underlying causes, as well as symptomatic management.1 9 In the majority of patients, symptoms completely resolve within a few weeks.1 10 We report a patient with generalised reversible encephalopathy syndrome resembling PRES, with severe neurological signs and symptoms.

Case presentation

A 74-year-old woman was admitted to the department of internal medicine, with anaemia due to an adenocarcinoma of the gastric cardia with metastases to the abdominal lymph nodes and liver, which was diagnosed a few weeks previously. Prior to admission, she had received no antitumour treatment. Medical history revealed hypertonia, which was treated with propranolol, as well as a recent urinary tract infection, for which antibiotics (ciprofloxacin) were administered. Ciprofloxacin was switched to sulbactam/ampicillin 2×3 g parenterally due to ongoing elevated infection parameters (CRP 5.91 mg/dL; leucocytes: 11.3 G/L). The patient's blood pressure was reported to be normal to mildly elevated on admission.

Owing to anaemia (haemoglobin: 7.0 g/dL), the patient received 2 units of packed red blood cells and major bleedings were ruled out as possible causes of blood loss.

On day 5 after admission, the patient experienced a generalised tonic-clonic seizure. Within the next 24 h, she had a series of complex-focal seizures. At this time, physical examination revealed fever (39.2°C), atrial flutter (160 bpm) and severe hypertension (200/100 mm Hg). Neurological examination showed a somnolent patient with homonymous hemianopsia, flaccid tetraparesis with hyporeflexia and a positive Babinski sign on both sides. Laboratory findings exhibited mild renal and liver failure (serum creatinine: 1.18 mg/dL; blood urea nitrogen: 17.4 mg/dL; aspartate aminotransferase: 87 U/L; alanine transaminase: 50 U/L; lactate dehydrogenase: 713 U/L; γ-glutamyl transpeptidase: 537 U/L; alkaline phosphatase: 381 U/L, serum albumine: 3.6 g/dL) mild anaemia (haemoglobin: 11.6 g/dL) and elevated infection parameters (C reactive protein: 6.62 mg/dL, leucocytes: 12.8 G/L).

CT imaging of the brain showed diffuse, bihemispheric white matter hypodensity. MRI demonstrated widespread, almost symmetric, hyperintense lesions, predominantly in the white matter on fluid attenuated inversion recovery (figure 1). Diffusion-weighted imaging showed no evidence of infarction and imaging with gadolinium showed no pathological enhancement. Based on radiological findings and neurological signs and symptoms, PRES was diagnosed and the patient was transferred to the department of Neurology. At this time, her neurological condition was unchanged.

Figure 1.

Figure 1

Brain MRI. Development of multiple, generalised hypertense lesions on axial fluid-attenuated inversion recovery (FLAIR) at diagnosis, at day 10 and day 20.

Differential diagnosis

  1. MRI changes possibly caused by seizures.

  2. Progressive Multifocal Leucoencephalopathy.

Treatment

Initial treatment comprised of antihypertensive therapy with intravenous application of urapidil as well as antiepileptic therapy with levetiracetam and clobazam. Antibiotic therapy was changed to meropenem 3×1 g per day, which finally proved clinically effective.

Although cerebrospinal fluid examination was unremarkable, due to the unusual generalised appearance of leucoencephalopathy, the patient received corticosteroids for possible immune-mediated leucoencephalopathy syndrome.

Outcome and follow-up

Within a few days, concurrently with the normalisation of blood pressure, the patient's impairment of consciousness as well as the flaccid tetraparesis improved. Follow-up MRI performed at days 10 and 20 also showed improvement of hyperintense lesions on FLAIR (figure 1). Based on the clinical and radiological development, the diagnosis of PRES was reinforced. The patient was discharged 21 days after the onset of neurological symptoms. She was alert and fully oriented, with persistent mild to moderate tetraparesis and normal blood pressure. The patient died 11 days later due to adenocarcinoma of the gastric cardia. No autopsy was performed.

Discussion

This case study reports an unusual generalised reversible encephalopathy syndrome. Although the diagnosis resembles PRES, possible synergistic factors contributing to the unusual and generalised presentation should be discussed.

In PRES, hyperintense lesions are predominantly located in the subcortical white matter of the posterior occipital and parietal lobes.1 5 Despite its name, as a ‘posterior’ encephalopathy syndrome, PRES can also occur in atypical locations. While involvement of the frontal lobe and cerebellum are commonly reported, the brainstem, cortex, basal ganglia and deep white matter are less frequently affected.3 5 A detailed list of site-dependent frequencies of MRI changes in PRES is reported by McKinney et al6: posterior frontal, 78.9%; temporal, 68.4%; thalamus, 30.3%; cerebellum, 34.2%; brainstem, 18.4%; and basal ganglia, 11.8%. In the present case, MRI of the brain showed generalised, widespread hyperintense FLAIR and T2-lesions involving the occipital, temporal, parietal and frontal lobes, as well as the cerebellum, pons and splenium.

The association between PRES and arterial hypertension is well documented,1 2 8 although patients without hypertension are also reported to develop PRES.5 6 Seventy to eighty per cent of patients with PRES present with hypertension at time of symptom onset.2 3 Although our patient presented mild hypertension during the previous days, blood pressure was only severely elevated at the time of symptom onset. Under intravenous hypertensive therapy, clinical symptoms, especially consciousness, improved, as did radiological findings. Several studies showed that T2-hyperintense lesions are more extensive in patients with normal blood pressure compared to those with severe hypertension.7 11 In our patient, we found generalised T2 hyperintensity, meaning that hypertensive crisis was probably not the major underlying cause.

Bartynski et al7 showed an association between PRES and infection, sepsis and shock, occurring 2 weeks after bacteraemia or organ/tissue infection. Prior to admission, our patient was treated with ciprofloxacin due to a urinary tract infection. At the time of the clinical manifestation of PRES, she presented with fever, and laboratory findings revealed elevated parameters of infection. Although no focus could be found, antibiotic therapy was changed at the same time as when intravenous antihypertensive therapy was initiated. Therefore, a possible association between clinical and radiological improvement after antipyretic as well as antibiotic treatment may also be considered.

The patient also received 2 units of packed red blood cells due to anaemia. The literature also suggests an association between blood transfusion followed by PRES.12 13 All reported cases affected patients with chronic anaemia who received a large volume of blood within a short time, whereby haemoglobin increased by about 5 g/dL. In all cases, PRES occurred 2–7 days after blood transfusion. In our case, the patient received a lesser volume and the haemoglobin level only increased by 3 g/dL. Despite the small volume, blood transfusion may have triggered the development of PRES, coexisting with other risk factors such as hypertension and infection.

Chemotherapy is a well-documented risk factor of PRES.2 9 Moreover, tumour lysis syndrome and hypercalcaemia due to cancer have been reported as risk factors for PRES.14 15 Our patient received no anticancer treatment, while serum-calcium was also normal. It remains unclear whether there is a correlation between PRES and malignancy by itself.

Transient MRI changes after seizures, such as contrast enhancement, increased T2 fluid-attenuated inversion recovery and diffusion weighted imaging, have been reported.16 17 These MRI changes are often cortically accentuated, and have a more unilateral distribution and involvement of hippocampal structures; also, an association with meningeal enhancement is reported.16–18 To what extent the initial series of complex partial seizures in our patient contributed to the signal changes on MRI remains unclear. However, the characteristics of MRI changes due to seizures show a different pattern as compared to the generalised MRI changes predominately in the white matter without meningeal contrast enhancement in our patient.

Another differential diagnosis is the progressive multifocal leucoencephalopathy syndrome (PML). PML typically shows widespread, asymmetric, hyperintense T2-lesions and FLAIR-lesions of the white matter, especially in parieto-occipital and frontal lobe.19 20 PML is usually associated with an immunosuppressive state and shows, in contrast to our case study, a clinical and radiological progression.19 21

Learning points.

  • Posterior reversible encephalopathy syndrome (PRES) can also occur in atypical locations.

  • Several risk factors can cause PRES.

  • The coexistence of several risk factors may lead to unusual clinical and radiological findings of PRES.

Footnotes

Contributors: JK is the author of the case report. HW is co-author. SO is senior author and corresponding author.

Competing interests: None declared.

Patient consent: Not Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Hinchey J, Chaves C, Appignani B et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500. 10.1056/NEJM199602223340803 [DOI] [PubMed] [Google Scholar]
  • 2.Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008;29:1036–42. 10.3174/ajnr.A0928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fugate J, Claassen D, Cloft H et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2008;85:427–32. 10.4065/mcp.2009.0590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Servillo G, Bifulco F, De Robertis E et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 2007;33:230–6. 10.1007/s00134-006-0459-0 [DOI] [PubMed] [Google Scholar]
  • 5.Bartynski WS, Boardman JF. Distinct imaging patters and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2007;28:1320–7. 10.3174/ajnr.A0549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.McKinney AM, Short J, Truwit CL et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904–12. 10.2214/AJR.07.2024 [DOI] [PubMed] [Google Scholar]
  • 7.Bartynski WS, Boardman JF, Zeigler ZR et al. Posterior reversible encephalopathy syndrome in infection, sepsis and shock. AJNR Am J Neuroradio 2006;27:2179–90. [PMC free article] [PubMed] [Google Scholar]
  • 8.Liman TG, Bohner G, Heuschmann PU et al. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J Neurol 2012;259:155–64. 10.1007/s00415-011-6152-4 [DOI] [PubMed] [Google Scholar]
  • 9.Staykov D, Schwab S. [Posteriores reversibles enzephalopathie syndrom]. Nervenarzt 2012;83:1013–20. 10.1007/s00115-012-3480-2 [DOI] [PubMed] [Google Scholar]
  • 10.Roth C, Ferbert A. Posterior reversible encephalopathy syndrome: long-term follow-up. J Neurol Neurosurg Psychiatry 2010;81:773–7. 10.1136/jnnp.2009.189647 [DOI] [PubMed] [Google Scholar]
  • 11.Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2009;29:447–55. 10.3174/ajnr.A0839 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Huang YC, Tsai PL, Yeh JH et al. Reversible posterior leucoencephalopathy syndrome caused by blood transfusion: a case report. Acta Neurol Taiwan 2008;17:258–62. [PubMed] [Google Scholar]
  • 13.Boughammoura A, Touzé E, Oppenheim C et al. Reversible angiopathy and encephalopathy syndrome after blood transfusion. J Neurol 2003;250:116–18. [DOI] [PubMed] [Google Scholar]
  • 14.Nakajima N, Ueda M, Nagayama H et al. Posterior reversible encephalopathy syndrome due to hypercalcemia associated with parathyroid hormone-related peptide: a case report and review of the literature. Intern Med 2013;52:2465–8. 10.2169/internalmedicine.52.0444 [DOI] [PubMed] [Google Scholar]
  • 15.Kaito E, Terae S, Kobayashi R et al. The role of tumor lysis in reversible posterior leukoencephalopathy syndrome. Pediatric Radiol 2005;35:722–7. 10.1007/s00247-005-1434-6 [DOI] [PubMed] [Google Scholar]
  • 16.Milligan TA, Zamani A, Bromfield E. Frequency and patterns of MRI abnormalities due to status epilepticus. Seizure 2009;18:104–8. 10.1016/j.seizure.2008.07.004 [DOI] [PubMed] [Google Scholar]
  • 17.Palmeri B, Talamanca S, Ragonese P et al. MRI abnormalities following repeated and incoming seizures. Seizure 2011;20:90–2. 10.1016/j.seizure.2010.09.012 [DOI] [PubMed] [Google Scholar]
  • 18.Cianfoni A, Caulo M, Cerase A et al. Seizure-induced brain lesions: a wide spectrum of variably reversible MRI abnormalities. Eur J Radiol 2013;82: 1964–72. 10.1016/j.ejrad.2013.05.020 [DOI] [PubMed] [Google Scholar]
  • 19.Whiteman ML, Post MJ, Berger JR et al. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993;187:233–40. 10.1148/radiology.187.1.8451420 [DOI] [PubMed] [Google Scholar]
  • 20.Berger JR, Pall L, Lanska D et al. Progressive multifocal leukoencephalopathy in patients with HIV infection . J Neurovirol 1998;4:59–68. 10.3109/13550289809113482 [DOI] [PubMed] [Google Scholar]
  • 21.Post MJ, Yiannoutsos C, Simpson D et al. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. AJNR Am J Neuroradiol 1999;20:1896–906. [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES